Vest Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.3M Sell
14,066
-192
-1% -$227K 0.17% 146
2026
Q2
$17.1M Buy
14,258
+232
+2% +$237K 0.18% 142
2026
Q1
$12.9M Buy
14,026
+10,715
+324% +$10.9M 0.15% 143
2025
Q4
$3.56M Sell
3,311
-8,017
-71% -$7.67M 0.05% 257
2025
Q3
$8.64M Buy
11,328
+2,178
+24% +$1.62M 0.11% 145
2025
Q2
$7.13M Buy
9,150
+2,580
+39% +$2M 0.1% 143
2025
Q1
$5.43M Buy
6,570
+2,782
+73% +$2.31M 0.08% 146
2024
Q4
$2.92M Buy
3,788
+453
+14% +$375K 0.05% 125
2024
Q3
$2.95M Buy
3,335
+2,224
+200% +$2M 0.06% 125
2024
Q2
$1.01M Sell
1,111
-31
-3% -$24.8K 0.02% 202
2024
Q1
$888K Buy
+1,142
New +$813K 0.02% 158

Other funds holding LLY

Vest Financial's LLY Position: Q3 2026 in Review

Vest Financial reduced its Eli Lilly (LLY) stake by 1.3% in Q3 2026, selling an estimated $227K and leaving 14,066 shares worth $16.3M. The position accounts for 0.17% of the portfolio, ranked #146.

Vest Financial first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. The position peaked at $17.1M in Q2 2026. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Vest Financial held 14,066 shares of Eli Lilly worth $16.3M as of Q3 2026.
  • Vest Financial sold 192 Eli Lilly shares in Q3 2026, an estimated $227K.
  • Eli Lilly made up 0.17% of Vest Financial's portfolio in Q3 2026, its #146 holding.
  • Vest Financial first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
  • Vest Financial's Eli Lilly position peaked at $17.1M in Q2 2026.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Vest Financial's 13F filing for Q3 2026, filed 21 Oct 2026.